Welcome back to the podcast, bribe, swindle, or steel.

I'm Alexandra Rogge, and today we're talking about bribery and the opioid crisis,

including the recent incis therapeutics conviction.

My guest is Brad Bailey, a Boston-based criminal defense lawyer.

Brad is a former federal prosecutor, and now in private practice at his own firm, he has represented

individuals facing charges of public corruption and federal racketeering.

His experience in white-collar crime extends to the pharmaceutical industry and its role

in perpetuating the national opioid crisis, a topic on which he has been quoted widely.

Brad, thanks so much for joining me.

My pleasure to be here.

Can you start by setting the scene for us,

particularly for our non-U.S. listeners

who will be less familiar with the story?

The United States Attorney's Office in the District of Massachusetts,

I recently completed a lengthy racketeering

trial against a southwestern United States-based pharmaceutical company called Incis.

And the allegation at issue there was that the principles at Incis were in an effort to

distribute a fentanyl-based pain-killing spray were bribing doctors and engaging in acts of racketeering as a group, criminal acts, in order to push

their fentanyl or opioid-based product into the marketplace.

Amongst the allegations were the fact that they were bribing doctors by phony dinner speakers programs to write

large amounts of prescriptions, that they were lying to health insurance companies about

coverage, that they were hiring and putting on company payroll, office personnel in order to

...